CenterBook Partners LP Has $5.47 Million Stock Holdings in Huron Consulting Group Inc. (NASDAQ:HURN)

CenterBook Partners LP decreased its stake in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 11.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 38,109 shares of the business services provider's stock after selling 4,848 shares during the period. CenterBook Partners LP owned 0.22% of Huron Consulting Group worth $5,467,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of HURN. Charles Schwab Investment Management Inc. boosted its holdings in shares of Huron Consulting Group by 1.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 205,376 shares of the business services provider's stock worth $25,520,000 after acquiring an additional 3,783 shares during the period. Raymond James Financial Inc. bought a new position in shares of Huron Consulting Group during the fourth quarter worth approximately $1,301,000. Avantax Advisory Services Inc. acquired a new stake in Huron Consulting Group during the 4th quarter worth approximately $213,000. Cibc World Markets Corp bought a new stake in Huron Consulting Group in the 4th quarter valued at $204,000. Finally, William Blair Investment Management LLC grew its holdings in Huron Consulting Group by 2.5% in the 4th quarter. William Blair Investment Management LLC now owns 256,971 shares of the business services provider's stock valued at $31,931,000 after buying an additional 6,338 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company's stock.

Huron Consulting Group Price Performance

HURN stock traded up $0.16 during midday trading on Wednesday, reaching $132.34. The company had a trading volume of 146,401 shares, compared to its average volume of 156,355. Huron Consulting Group Inc. has a 1-year low of $101.73 and a 1-year high of $155.00. The stock has a 50 day moving average price of $141.08 and a 200-day moving average price of $137.74. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.08 and a quick ratio of 2.08. The company has a market capitalization of $2.28 billion, a price-to-earnings ratio of 19.84 and a beta of 0.28.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.52. Huron Consulting Group had a return on equity of 24.68% and a net margin of 7.88%. The company had revenue of $404.14 million for the quarter, compared to analyst estimates of $389.27 million. During the same quarter last year, the company posted $1.23 EPS. The company's revenue for the quarter was up 11.2% compared to the same quarter last year. Equities research analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Insider Activity at Huron Consulting Group

In related news, Director H Eugene Lockhart sold 1,040 shares of Huron Consulting Group stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $136.74, for a total transaction of $142,209.60. Following the sale, the director directly owned 8,162 shares in the company, valued at $1,116,071.88. This trade represents a 11.30% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John Mccartney sold 500 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $136.74, for a total transaction of $68,370.00. Following the sale, the director directly owned 51,817 shares in the company, valued at $7,085,456.58. The trade was a 0.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,708 shares of company stock valued at $377,421 in the last 90 days. 2.15% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. William Blair reissued an "outperform" rating on shares of Huron Consulting Group in a report on Wednesday, March 26th. Wedbush lifted their price objective on shares of Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research note on Wednesday, March 26th. Wall Street Zen downgraded shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a report on Friday, May 2nd. Barrington Research raised their target price on shares of Huron Consulting Group from $167.00 to $173.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Finally, Benchmark reiterated a "buy" rating and issued a $165.00 price target on shares of Huron Consulting Group in a research report on Wednesday, March 26th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $170.75.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.